Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma

NCT06940700 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: SHR4597
DRUG: Budesonide inhalant

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd